| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000012356 |
| Receipt No. | R000014312 |
| Official scientific title of the study | The randomized controlled trial on the effects of aromatherapy for the cancer patients |
| Date of disclosure of the study information | 2013/11/22 |
| Last modified on | 2018/05/25 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | The randomized controlled trial on the effects of aromatherapy for the cancer patients | |
| Title of the study (Brief title) | The randomized controlled trial on the effects of aromatherapy for the cancer patients | |
| Region |
|
|
| Condition | |||
| Condition | Hepatocellular carcinoma,
Cholangiocarcinoma, Pancreatic cancer Gastric cancer |
||
| Classification by specialty |
|
||
| Classification by malignancy | Malignancy | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | In aromatherapy with treatment method, we'd like to confirm the usefulness of multiple treatment. Therefore, we will conduct the prospective study comparing the group performed multiple treatments and the group performed single treatment in order to study the changes in quality of life. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Quality of life |
| Key secondary outcomes | Serological marker
Salivary stress marker |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Dose comparison |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | Institution is considered as a block. |
| Blocking | YES |
| Concealment | Numbered container method |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Multiple treatments group: 6 times/12 weeks
|
|
| Interventions/Control_2 | Single treatment group: once/12 weeks | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1.Patients at Juntendo University Nerima Hospital with a diagnosis of cancer clinically or histologically visit outpatient chemotherapy regulary, and their prognosis can be expected three months or more.
2.ECOG performance status of the patients with 0 or 1. 3.Patients were obtained consent by performing a sufficient explanation prior to the start of the study for the study entry. |
|||
| Key exclusion criteria | 1.By receiving the aromatherapy treatments, physical symptoms of the patient becomes worse.
2.Patients who can not fill out the questionnaire. |
|||
| Target sample size | 80 | |||
| Research contact person | |
| Name of lead principal investigator | Hironao Okubo |
| Organization | Juntendo University Nerima Hospital |
| Division name | Gastroenterology |
| Address | 3-1-10, takanodai, nerima-ku, Tokyo, Japan |
| TEL | 03-5923-3111 |
| drokubo@juntendo-nerima.jp | |
| Public contact | |
| Name of contact person | Hironao Okubo |
| Organization | Juntendo University Nerima Hospital |
| Division name | Gastroenterology |
| Address | 3-1-10, takanodai, nerima-ku, Tokyo, Japan |
| TEL | 03-5923-3111 |
| Homepage URL | |
| drokubo@juntendo-nerima.jp | |
| Sponsor | |
| Institute | Juntendo University Nerima Hospital
Gastroenterology |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000014312 |